New Silk Road Investment Pte LTD I Mab Transaction History
New Silk Road Investment Pte LTD
- $50.4 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
35Shares Held
16.5MCall Options Held
0Put Options Held
14.5K-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$5.5 Million0.19% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$3.83 Million3.04% of portfolio
-
Morgan Stanley New York, NY3.54MShares$3.26 Million0.0% of portfolio
-
Sg Americas Securities, LLC476KShares$437,7930.0% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny431KShares$396,3360.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $76.5M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...